A series of antigens targeting surface proteins, including EGFR, CEA, MSLN, HER2, ROR1, MUC1, and DLL3 in lung carcinoma cells have been incorporated into CAR structure to allow CAR-T cells target lung cancer tissue. This evidence concerns the gene ERBB2 and lung cancer.